Evidence map›Paper›PMID 37273670›Full record

ArticleClinical case reports2023

First confirmed case of multisystem inflammatory syndrome in adult in Egypt.

Mohamed Abdel-Salam Elgohary, Mohamed Emam Mohamed, Mahmoud Moustafa Hamada, Jackline S Fahim, Thanaa A El-Masry, Ahmed Mohamed Ibrahim, Ahmad Gad Taha, Mohamed G Seadawy, Athanasios Alexiou, Marios Papadakis and 2 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 4 countries.

Mohamed Abdel-Salam ElgoharyAlmaza Fever Hospital Cairo Egypt.
Mohamed Emam MohamedCOVID Isolation Department Almaza Fever Hospital Cairo Egypt.
Mahmoud Moustafa HamadaCOVID Isolation Department Almaza Fever Hospital Cairo Egypt.
Jackline S FahimMicrobiolgy Laboratory Department Almaza Fever Hospital Cairo Egypt.
Thanaa A El-MasryDepartment of Pharmacology and Toxicology, Faculty of Pharmacy Tanta University Tanta Egypt.
Ahmed Mohamed IbrahimCOVID Isolation Department Almaza Fever Hospital Cairo Egypt.
Ahmad Gad TahaVirology Laboratory Department Central Military Laboratories Cairo Egypt.
Mohamed G SeadawyBiological Prevention Department Ministry of Defense Cairo Egypt.
Athanasios AlexiouDepartment of Science and Engineering Novel Global Community Educational Foundation Hebersham New South Wales Australia.ORCID https://orcid.org/0000-0002-2206-7236
Marios PapadakisDepartment of Surgery II, University Hospital Witten-Herdecke, Heusnerstrasse 40 University of Witten-Herdecke Wuppertal Germany.
Gaber El-Saber BatihaDepartment of Pharmacology and Therapeutics, Faculty of Veterinary Medicine Damanhour University Damanhour Egypt.
Maisra M El-BousearyDepartment of Pharmaceutical Microbiology, Faculty of Pharmacy Tanta University Tanta Egypt.ORCID https://orcid.org/0000-0001-6503-0719
Adam International Hospital · EGTanta University · EGCentral Laboratory For Agricultural Expert Systems · EGDamanhour University · EGMilitary Technical College · EGMinistry of Defence · GBWitten/Herdecke University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Key Clinical Message: Our case report demonstrates extremely uncommon data associated with MIS-A, such as cholestatic jaundice, anemia, and quickly progressing pneumonia. IVIG and pulse steroid medications are the best treatments for improving clinical outcomes. Abstract: We report a case of multiple organ dysfunctions due to MIS-A in an adult with a history of suspected COVID-19. Our case demonstrates extremely uncommon data associated with MIS-A, such as cholestatic jaundice, anemia, and quickly progressing pneumonia. IVIG and pulse steroid medications are the best treatments for improving clinical outcomes.

Indexed as

COVID‐19MIS‐AMIS‐Cmultiple organ dysfunctionsSARS‐CoV‐2 infection

Identifiers

PMID37273670
PMCPMC10233214
OpenAlexW4379054311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.